$279.56
+
$4.06 (1.47%)
End-of-day quote: 05/07/2024
ASX:CSL
CSL Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr882.60 | kr696.07 | 0.00% | 14 | kr3.94T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $148.72 | $174.55 | 0.00% | 3 | $357.92B |
| MRK | Merck | NYSE | Outperform | $130.38 | $130.51 | 0.00% | 11 | $330.23B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.18 | £165.99 | 0.00% | 16 | £187.86B |
| NOVN | Novartis | SWX | Hold | CHF89.78 | CHF105.00 | 0.00% | 9 | CHF183.19B |
| ABT | Abbott Laboratories | NYSE | Outperform | $106.17 | $118.92 | 0.00% | 7 | $184.70B |
| PFE | Pfizer | NYSE | Outperform | $27.77 | $32.87 | 0.00% | 6 | $157.25B |
| SAN | Sanofi | ENXTPA | Outperform | 91.88€ | 102.80€ | 0.00% | 9 | 114.73€B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $410.24 | $457.59 | 0.00% | 11 | $105.96B |
| GSK | GSK | LSE | Outperform | £17.61 | £17.30 | 0.00% | 12 | £71.81B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.46 | $87.82 | 0.00% | 14 | $81.63B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.10k | ¥4.74k | 0.00% | 0 | ¥6.43T |
| BIIB | Biogen | NasdaqGS | Outperform | $218.92 | $299.62 | 0.00% | 13 | $31.87B |
| BAYN | Bayer | XTRA | Hold | 28.49€ | 45.15€ | 0.00% | 4 | 27.98€B |
| UCB | UCB | ENXTBR | Outperform | 119.90€ | 102.66€ | 0.00% | 7 | 22.75€B |
| BAX | Baxter International Inc | NYSE | Outperform | $36.12 | $44.86 | 0.00% | 5 | $18.41B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.56k | ¥2.64k | 0.00% | 0 | ¥2.80T |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr280.80 | kr293.00 | 0.00% | 6 | kr97.00B |
| 002252 | Shanghai RAAS Blood Products | SZSE | Buy | ¥7.35 | ¥9.08 | 0.00% | 0 | ¥47.71B |
| 600161 | Beijing Tiantan Biological Pro... | SHSE | Outperform | ¥29.91 | ¥31.28 | 0.00% | 1 | ¥47.41B |
| GRF | Grifols | BME | Outperform | 9.29€ | 18.48€ | 0.00% | 3 | 5.32€B |
| 002007 | Hualan Biological Engineering | SZSE | Outperform | ¥19.70 | ¥25.89 | 0.00% | 0 | ¥35.61B |
| ITRI | Itron | NasdaqGS | Outperform | $108.25 | $77.33 | 0.00% | 0 | $4.91B |
| BIOCON | Biocon | NSEI | Hold | Rp295.05 | Rp270.86 | 0.00% | 14 | Rp356.47B |
| PFIZER | Pfizer | NSEI | Outperform | Rp4.26k | Rp4.53k | 0.00% | 3 | Rp194.76B |
| ADMA | ADMA Biologics | NasdaqGM | Buy | $6.91 | $6.00 | 0.00% | 0 | $1.51B |
| BIO3 | Biotest | XTRA | Hold | 27.90€ | 37.00€ | 0.00% | 0 | 1.38€B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $5.26 | $14.09 | 0.00% | 2 | $1.09B |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.90€ | 1.85€ | 0.00% | 2 | 590.27€M |
| NVAX | Novavax | NasdaqGS | Outperform | $4.61 | $23.25 | 0.00% | 4 | $603.61M |
| 4105 | TTY Biopharm Company | TPEX | Hold | NT$77.30 | NT$86.00 | 0.00% | 0 | NT$19.22B |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $12.19 | $20.80 | 0.00% | 0 | $478.84M |
| 4142 | Adimmune | TWSE | - | NT$31.05 | NT$55.00 | 0.00% | 0 | NT$14.08B |
| KENDR | Kendrion N.V. | ENXTAM | Outperform | 13.26€ | 15.17€ | 0.00% | 2 | 202.56€M |
| ABEO | Abeona Therapeutics | NasdaqCM | Buy | $4.56 | $21.25 | 0.00% | 2 | $207.08M |
| 6833 | Sinco Pharmaceuticals Holdings | SEHK | - | HK$0.24 | HK$0.46 | 0.00% | 0 | HK$528.55M |
| LUPA3 | Lupatech | BOVESPA | - | R$1.42 | R$1.90k | 0.00% | 0 | R$65.01M |
